文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

马拉维HIV暴露未感染婴儿抗菌药物处方分析(2004-2010)

Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010.
PubMed 文献 · Emerg Infect Dis · 2019-01-01

该研究分析了马拉维2004-2010年2152名HIV暴露未感染婴儿的抗菌药物处方情况。80%婴儿被处方抗菌药物,67%处方针对呼吸道适应症,青霉素和磺胺类最常见。接受复方新诺明预防治疗、抗逆转录病毒药物及年龄增长与较低处方风险相关。

要点

  • HIV暴露未感染婴儿抗菌药物处方频繁,80%在出生第一年内被处方。
  • 复方新诺明预防治疗与抗菌药物处方风险降低相关。
  • 呼吸道适应症占抗菌药物处方的67%。

核心结论

  • HIV暴露未感染婴儿抗菌药物处方频繁,复方新诺明预防治疗可能减少后续抗菌药物处方。

研究设计与样本

  • 研究纳入马拉维利隆圭母乳喂养、抗逆转录病毒与营养研究中2004-2010年入组的2152名HIV暴露未感染婴儿,随访至出生后第一年。

主要发现

  • 80%的婴儿被处方抗菌药物,5329次处方中67%针对呼吸道适应症。
  • 最常处方的是青霉素类(43%)和磺胺类(23%)。
  • 接受复方新诺明预防治疗、接受抗逆转录病毒药物及年龄增长与抗菌药物处方风险降低相关。

临床怎么用

  • 对HIV暴露未感染婴儿应重视抗菌药物合理使用,并考虑复方新诺明预防治疗的潜在获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antimicrobial drug resistance is a serious health hazard driven by overuse. Administration of antimicrobial drugs to HIV-exposed, uninfected infants, a population that is growing and at high risk for infection, is poorly studied. We therefore analyzed factors associated with antibacterial drug administration to HIV-exposed, uninfected infants during their first year of life. Our study population was 2,152 HIV-exposed, uninfected infants enrolled in the Breastfeeding, Antiretrovirals and Nutrition study in Lilongwe, Malawi, during 2004-2010. All infants were breastfed through 28 weeks of age. Antibacterial drugs were prescribed frequently (to 80% of infants), and most (67%) of the 5,329 prescriptions were for respiratory indications. Most commonly prescribed were penicillins (43%) and sulfonamides (23%). Factors associated with lower hazard for antibacterial drug prescription included receipt of cotrimoxazole preventive therapy, receipt of antiretroviral drugs, and increased age. Thus, cotrimoxazole preventive therapy may lead to fewer prescriptions for antibacterial drugs for these infants.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ewing AC, Davis NL, Kayira D, et al. Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004-2010. Emerg Infect Dis. 2019. PMID: 30561313. doi:10.3201/eid2501.180782

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。